Literature DB >> 20926125

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.

Jean Bousquet1, Eva Mantzouranis, Alvaro A Cruz, Nadia Aït-Khaled, Carlos E Baena-Cagnani, Eugene R Bleecker, Chris E Brightling, Peter Burney, Andrew Bush, William W Busse, Thomas B Casale, Moira Chan-Yeung, Rongchang Chen, Badrul Chowdhury, Kian Fan Chung, Ronald Dahl, Jeffrey M Drazen, Leonardo M Fabbri, Stephen T Holgate, Francine Kauffmann, Tari Haahtela, Nikolaï Khaltaev, James P Kiley, Mohammad R Masjedi, Yousser Mohammad, Paul O'Byrne, Martyn R Partridge, Klaus F Rabe, Alkis Togias, Christiaan van Weel, Sally Wenzel, Nanshan Zhong, Torsten Zuberbier.   

Abstract

Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Concepts of asthma severity and control are important in evaluating patients and their response to treatment, as well as for public health, registries, and research (clinical trials, epidemiologic, genetic, and mechanistic studies), but the terminology applied is not standardized, and terms are often used interchangeably. A common international approach is favored to define severe asthma, uncontrolled asthma, and when the 2 coincide, although adaptation may be required in accordance with local conditions. A World Health Organization meeting was convened April 5-6, 2009, to propose a uniform definition of severe asthma. An article was written by a group of experts and reviewed by the Global Alliance against Chronic Respiratory Diseases review group. Severe asthma is defined by the level of current clinical control and risks as "Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death) and/or adverse reactions to medications and/or chronic morbidity (including impaired lung function or reduced lung growth in children)." Severe asthma includes 3 groups, each carrying different public health messages and challenges: (1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) treatment-resistant severe asthma. The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20926125     DOI: 10.1016/j.jaci.2010.07.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  171 in total

1.  Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma.

Authors:  Amanda Sutcliffe; Fay Hollins; Edith Gomez; Ruth Saunders; Camille Doe; Marcus Cooke; R A John Challiss; Chris E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2011-11-22       Impact factor: 21.405

2.  Fuzzy rule-based expert system for assessment severity of asthma.

Authors:  Maryam Zolnoori; Mohammad Hossein Fazel Zarandi; Mostafa Moin; Shahram Teimorian
Journal:  J Med Syst       Date:  2010-12-03       Impact factor: 4.460

3.  Can bariatric surgery be performed safely in patients with severe treatment-resistant asthma?

Authors:  Joseph Jia Hong Toh; Shanker Pasupathy; Ruban A L Poopalalingam; Mariko Siyue Koh
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 4.  Severe asthma: an expanding and mounting clinical challenge.

Authors:  Matthew C Bell; William W Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2013-02-26

Review 5.  Severe asthma in school-age children: evaluation and phenotypic advances.

Authors:  Andrea Coverstone; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 6.  Effects and mechanisms of actions of Chinese herbal medicines for asthma.

Authors:  Min-Li Hong; Ying Song; Xiu-Min Li
Journal:  Chin J Integr Med       Date:  2011-07-03       Impact factor: 1.978

7.  Assessing the Prevalence and Incidence of Asthma and Chronic Obstructive Pulmonary Disease in the Eastern Mediterranean Region.

Authors:  Mohammadreza Masjedi; Elaheh Ainy; Faried Zayeri; Rogayeh Paydar
Journal:  Turk Thorac J       Date:  2018-04-01

8.  Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response.

Authors:  Chang Xiao; Jocelyn M Biagini Myers; Hong Ji; Kelly Metz; Lisa J Martin; Mark Lindsey; Hua He; Racheal Powers; Ashley Ulm; Brandy Ruff; Mark B Ericksen; Hari K Somineni; Jeffrey Simmons; Richard T Strait; Carolyn M Kercsmar; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2015-04-21       Impact factor: 10.793

Review 9.  Role of monoclonal antibodies in the treatment of asthma.

Authors:  Paul M O'Byrne
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

10.  Quantitative sputum cell counts to monitor bronchitis: a qualitative study of physician and patient perspectives.

Authors:  Liesel D'silva; Helen Neighbour; Amiram Gafni; Katherine Radford; Freddy Hargreave; Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.